You are here » Home » Vídeos » Safety and Immunogenicity of First-in-Human Mosquito Saliva Peptide Vaccine
Safety and Immunogenicity of First-in-Human Mosquito Saliva Peptide Vaccine
Safety and Immunogenicity of First-in-Human Mosquito Saliva Peptide Vaccine
Share:
A sessão científica da Fiocruz Bahia "Safety and Immunogenicity of First-in-Human Mosquito Saliva Peptide Vaccine" foi realizada no dia 28 de agosto de 2020, através do Zoom. A palestra foi ministrada por Jessica Manning, do NIAID Cambodia.